TMEM126B expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.434600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.688000E-01
Normal-vs-Stage2
5.678000E-01
Normal-vs-Stage3
4.305200E-01
Normal-vs-Stage4
5.338000E-01
Stage1-vs-Stage2
7.982600E-01
Stage1-vs-Stage3
5.336600E-01
Stage1-vs-Stage4
8.387000E-01
Stage2-vs-Stage3
3.765600E-01
Stage2-vs-Stage4
9.320600E-01
Stage3-vs-Stage4
6.600800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.231000E-01
Normal-vs-AfricanAmerican
9.634000E-01
Normal-vs-Asian
6.607600E-01
Caucasian-vs-AfricanAmerican
3.931800E-01
Caucasian-vs-Asian
7.712800E-01
AfricanAmerican-vs-Asian
5.823800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.958800E-01
Normal-vs-Female
4.951400E-01
Male-vs-Female
8.327400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.243900E-02
Normal-vs-Age(41-60Yrs)
6.905800E-01
Normal-vs-Age(61-80Yrs)
5.289600E-01
Normal-vs-Age(81-100Yrs)
3.355600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.755800E-02
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.113400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.755700E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.126170E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.772000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.473800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.004800E-01
Normal-vs-Daily Drinker
3.928800E-01
Normal-vs-Weekly Drinker
3.147600E-01
Normal-vs-Occasional Drinker
4.935400E-01
Normal-vs-Social Drinker
5.731000E-01
Non Drinker-vs-Daily Drinker
9.797000E-01
Non Drinker-vs-Weekly Drinker
9.542400E-01
Non Drinker-vs-Occasional Drinker
4.725400E-01
Non Drinker-vs-Social Drinker
6.565800E-01
Daily Drinker-vs-Weekly Drinker
9.735000E-01
Daily Drinker-vs-Occasional Drinker
4.704800E-01
Daily Drinker-vs-Social Drinker
6.567600E-01
Weekly Drinker-vs-Occasional Drinker
4.434800E-01
Weekly Drinker-vs-Social Drinker
6.486600E-01
Occasional Drinker-vs-Social Drinker
8.654800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.419590E-01
Normal-vs-Grade 2
1.294460E-02
Normal-vs-Grade 3
4.197900E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.958600E-03
Grade 1-vs-Grade 3
1.348840E-01
Grade 1-vs-Grade 4
1.419590E-01
Grade 2-vs-Grade 3
3.274200E-01
Grade 2-vs-Grade 4
1.294460E-02
Grade 3-vs-Grade 4
4.197900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.637200E-01
Normal-vs-NonDiabetic
4.705800E-01
Diabetic-vs-NonDiabetic
3.467600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.468400E-01
Normal-vs-NoPancreatitis
4.406400E-01
Pancreatitis-vs-NoPancreatitis
7.008000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.267200E-01
Normal-vs-N1
5.506200E-01
N0-vs-N1
6.358400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.636600E-01
Normal-vs-TP53-NonMutant
6.056000E-01
TP53-Mutant-vs-TP53-NonMutant
7.558300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
